{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:47:12Z","timestamp":1793728032151,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273812"],"award-info":[{"award-number":["82273812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["23NSFSC3685"],"award-info":[{"award-number":["23NSFSC3685"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Health Commission of Sichuan Province","doi-asserted-by":"publisher","award":["21PJ106"],"award-info":[{"award-number":["21PJ106"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115784","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:21:15Z","timestamp":1698106875000},"page":"115784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Bruceine A: Suppressing metastasis via MEK\/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer"],"prefix":"10.1016","volume":"168","author":[{"given":"Xiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-0677","authenticated-orcid":false,"given":"Chen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuening","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115784_bib1","first-page":"147","article-title":"TNBCtype: a subtyping tool for triple-negative breast cancer","volume":"11","author":"Chen","year":"2012","journal-title":"Cancer Inf."},{"issue":"13","key":"10.1016\/j.biopha.2023.115784_bib2","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.7150\/thno.57706","article-title":"EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115784_bib3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jconrel.2020.10.015","article-title":"Nanoparticle-delivered miriplatin ultrasmall dots suppress triple negative breast cancer lung metastasis by targeting circulating tumor cells","volume":"329","author":"Li","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115784_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106415","article-title":"Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway","volume":"184","author":"Chen","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2023.115784_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154015","article-title":"Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K\/Akt\/mTOR signaling pathway by voacamine suppress breast cancer progression","volume":"99","author":"Zuo","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.115784_bib6","article-title":"Strategy conjugating PD-L1 polypeptide with doxorubicin alleviates chemotherapeutic resistance and enhances immune response in colon cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2023.115784_bib7","article-title":"Brusatol modulates diverse cancer hallmarks and signaling pathways as a potential cancer therapeutic","author":"Guo","year":"2022","journal-title":"Acta Mater. Med."},{"issue":"1","key":"10.1016\/j.biopha.2023.115784_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1292\/jvms.71.33","article-title":"Evaluation of efficacy of bruceine A, a natural quassinoid compound extracted from a medicinal plant, Brucea javanica, for canine babesiosis","volume":"71","author":"Nakao","year":"2009","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.biopha.2023.115784_bib9","doi-asserted-by":"crossref","first-page":"1149478","DOI":"10.3389\/fphar.2023.1149478","article-title":"Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K\/Akt pathway","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.115784_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.kint.2022.04.020","article-title":"Bruceine A protects against diabetic kidney disease via inhibiting galectin-1","volume":"102","author":"Li","year":"2022","journal-title":"Kidney Int."},{"issue":"22","key":"10.1016\/j.biopha.2023.115784_bib11","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2023.115784_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00562-5","article-title":"Implication of human endogenous retrovirus W family envelope in hepatocellular carcinoma promotes MEK\/ERK-mediated metastatic invasiveness and doxorubicin resistance","volume":"7","author":"Zhou","year":"2021","journal-title":"Cell Death Discov."},{"issue":"8","key":"10.1016\/j.biopha.2023.115784_bib13","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-12-3476","article-title":"Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E\/K-mutated melanoma","volume":"19","author":"Catalanotti","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2023.115784_bib14","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1158\/1535-7163.MCT-15-0243","article-title":"MEK inhibitor selumetinib (AZD6244; ARRY-142886) prevents lung metastasis in a triple-negative breast cancer xenograft model","volume":"14","author":"Bartholomeusz","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.biopha.2023.115784_bib15","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1158\/1078-0432.CCR-15-1125","article-title":"RAS\/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1\/PD-L1 immune checkpoint inhibitors","volume":"22","author":"Loi","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2023.115784_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/14656566.2023.2201372","article-title":"Pharmacoeconomics of novel pharmacotherapies in triple-negative breast cancer","volume":"24","author":"Boscolo Bielo","year":"2023","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.biopha.2023.115784_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41523-020-00197-2","article-title":"Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies","volume":"6","author":"Marra","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2023.115784_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000392","article-title":"Calcitriol-loaded dual-pH-sensitive micelle counteracts pro-metastasis effect of paclitaxel in triple-negative breast cancer therapy","volume":"9","author":"Zheng","year":"2020","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.biopha.2023.115784_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105658","article-title":"Bruceine A induces cell growth inhibition and apoptosis through PFKFB4\/GSK3beta signaling in pancreatic cancer","volume":"169","author":"Zhang","year":"2021","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115784_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s13046-019-1494-3","article-title":"MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt\/catenin beta and MEK\/ERK signaling pathways","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115784_bib21","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1007\/s13277-015-4345-7","article-title":"MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells","volume":"37","author":"Kim","year":"2016","journal-title":"Tumour Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223015822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223015822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:13:37Z","timestamp":1779916417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223015822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":21,"alternative-id":["S0753332223015822"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115784","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bruceine A: Suppressing metastasis via MEK\/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115784"}}